{
    "2019-08-30": [
        [
            {
                "time": "",
                "original_text": "健帆生物:肾科产品放量拉动内生强劲增长,扣非业绩增长超预期",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "肾科产品",
                        "放量",
                        "内生增长",
                        "扣非业绩",
                        "增长超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}